Pentobarbital will reduce the level or effect of fentanyl transmucosal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of fentanyl with CYP3A4 inducers could lead on to the minimize in fentanyl plasma concentrations, lack of efficacy or, possibly, development of the withdrawal syndrome in the client https://mcmasterz221rdq5.eedblog.com/profile